You have 9 free searches left this month | for more free features.

Tranfusion-dependent

Showing 1 - 25 of 4,035

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

MDS Trial in Boston (Peri-Transfusion QOL Assessment)

Completed
  • Myelodysplastic Syndromes
  • Peri-Transfusion QOL Assessment
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 6, 2022

Beta-Thalassemia Trial in Ferrara, Firenze, Pisa (Sirolimus 0.5 mg)

Recruiting
  • Beta-Thalassemia
  • Sirolimus 0.5 mg
  • Ferrara, FE, Italy
  • +3 more
Nov 11, 2021

Exposure to Polluted Air Trial in Yangzhou

Active, not recruiting
  • Exposure to Polluted Air
    • Yangzhou, Jiangsu, China
      Wenjing Zhao
    Feb 21, 2023

    PM2.5 Exposure and Ferroptosis in Seizures Patients

    Active, not recruiting
    • Exposure to Polluted Air
      • Wuxi, Jiangsu, China
        Affiliated Hospital of JiangNan University, Department of Pediat
      Mar 5, 2023

      Insufficient Breast Milk Syndrome Trial in Gainesville (Breast Pump suction pattern)

      Not yet recruiting
      • Insufficient Breast Milk Syndrome
      • Breast Pump suction pattern
      • Gainesville, Florida
        Neonatal intensive care unit at Shands children's hospital at th
      Sep 25, 2023

      Abuse Potential Trial in Overland Park (Placebo, Alprazolam 2 mg, Gabapentin Enacarbil Immediate Release (GE-IR) 200 mg)

      Completed
      • Abuse Potential
      • Placebo
      • +4 more
      • Overland Park, Kansas
        Altasciences Clinical Kansas
      Oct 19, 2023

      Thalassemia, Beta, Thalassemia Major Trial in Tianjin (VGB-Ex01)

      Not yet recruiting
      • Thalassemia, Beta
      • Thalassemia Major
      • VGB-Ex01
      • Tianjin, Tianjin, China
        Regenerative Medicine Center
      Sep 11, 2023

      Nephrotic Syndrome in Children, Telitacicept Trial in Hangzhou (Telitacicept)

      Recruiting
      • Nephrotic Syndrome in Children
      • Telitacicept
      • Hangzhou, Zhejiang, China
        Children's Hospital, Zhejiang University School of Medicine
      Nov 8, 2023

      OSA Trial in Boston (Dynamic CO2, Sham CO2)

      Not yet recruiting
      • OSA
      • Dynamic CO2
      • Sham CO2
      • Boston, Massachusetts
        Brigham and Women's Hospital
      Oct 16, 2023

      Stroke Trial (Educational intervention based on the Precede-Proceed Model for individuals caring for stroke home care patients)

      Not yet recruiting
      • Stroke
      • Educational intervention based on the Precede-Proceed Model for individuals caring for stroke home care patients
      • (no location specified)
      Jun 14, 2023

      Vineland II Scale of Long-term Development of Pyridoxine

      Not yet recruiting
      • Pyridoxine-Dependent Epilepsy
      • VINELAND II
      • Angers, France
        CHU Angers
      Sep 19, 2023

      Pain, Abuse, Drug, Intoxication; Cannabinoids Trial (Cannabis, Dronabinol, Smoked Placebo)

      Not yet recruiting
      • Pain
      • +2 more
      • (no location specified)
      May 9, 2023

      Effects of Lead Exposure on Ferroptosis Pathway

      Recruiting
      • Lead Poisoning
      • Neurotoxicity
      • Lead exposure
      • Yangzhou, Jiangsu, China
        Wenjing Zhao
      Jul 19, 2023

      MDS, Anemia Trial in Germany (Luspatercept Injection)

      Recruiting
      • Myelodysplastic Syndromes
      • Anemia
      • Luspatercept Injection
      • Berlin, Germany
      • +18 more
      Jan 25, 2023

      OSA Trial in Boston (Acetazolamide, Placebo)

      Not yet recruiting
      • OSA
      • Boston, Massachusetts
        Brigham and Women's Hospital
      Oct 16, 2023

      Intermittent Fasting, Aging Trial in Oklahoma City (Time restricted eating)

      Not yet recruiting
      • Intermittent Fasting
      • Aging
      • Time restricted eating
      • Oklahoma City, Oklahoma
        Translational GeroScience Laboratory
      Sep 5, 2023

      Nephrotic Syndrome Trial in United States (ADX-629)

      Not yet recruiting
      • Nephrotic Syndrome
      • Northridge, California
      • +10 more
      Jan 24, 2023

      Transfusion Dependent Beta-Thalassaemia Trial in Nanning (ET-01)

      Recruiting
      • Transfusion Dependent Beta-Thalassaemia
      • ET-01
      • Nanning, Guangxi, China
        PLA 923 Hospital
      Mar 2, 2023

      Life-dependent Home Mechanical Ventilation

      Enrolling by invitation
      • Ventilator Lung
        • GLostrup, Denmark
          Department of Anaesthesia, Pain and REspiratory Support
        Nov 21, 2023

        Hepatitis, Drug-Induced Trial in Denmark (Mycophenolate Mofetil, Tacrolimus, Solu-Medrol)

        Recruiting
        • Hepatitis, Drug-Induced
        • Mycophenolate Mofetil
        • +3 more
        • Herlev, Copenhagen, Denmark
        • +4 more
        Dec 11, 2022

        Nephrotic Syndrome in Children Trial in China (Adrenocorticotrophic Hormone, Steroid)

        Recruiting
        • Nephrotic Syndrome in Children
        • Wuhan, Hubei, China
        • +7 more
        Oct 8, 2023

        CRACK-TARGET 1: ÉTUDE DESCRIPTIVE DE LA SENSIBILISATION

        Not yet recruiting
        • Cocaine Use Disorder
        • Observation of behavior and search of biomarkers with 3 blood tests.3 weeks wearing an actimeter
        • 3 blood tests
        • Paris, France
          Hôpital Fernand Widal
        Sep 15, 2023

        Geriatrics, Home Care Services Trial (Home care intervention)

        Not yet recruiting
        • Geriatrics
        • Home Care Services
        • Home care intervention
        • (no location specified)
        Sep 30, 2022

        Nephrotic Syndrome in Children Trial in Chongqing (Rituximab, Mycophenolate Mofetil)

        Recruiting
        • Nephrotic Syndrome in Children
        • Chongqing, Chongqing, China
          Children's Hospital of Chongqing Medical University
        May 3, 2023

        Oxidative Stress, Inflammation Trial in Ede (Vitamin K2, Placebo)

        Active, not recruiting
        • Oxidative Stress
        • Inflammation
        • Vitamin K2
        • Placebo
        • Ede, Netherlands
          NIZO food research
        Feb 2, 2023